{"id":"W2958159650","doi":"10.1016/j.cgh.2019.07.010","title":"Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries","year":2019,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; Guangdong Provincial Pearl River Talents Program; AbbVie; Johnson and Johnson; Ministry of Science and Technology of the People's Republic of China; Bristol-Myers Squibb Canada; Gilead Sciences; Novartis; Roche; Merck; GlaxoSmithKline; Allergan; Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Hepatocellular carcinoma; Hazard ratio; Internal medicine; Hepatitis B virus; Hepatitis B; Adverse effect; Randomized controlled trial; Liver disease; Gastroenterology; Oncology; Immunology; Confidence interval; Virus; Lamivudine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005992417,0.00162098,0.003383032,0.0004864826,0.0008119611,0.00173356,0.0008883981,0.001988417,0.002908127],"category_scores_gemma":[0.006751858,0.0009079397,0.005913174,0.0008590819,0.001787638,0.001487558,0.001140179,0.002108002,0.0002696868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001297399,"about_ca_system_score_gemma":0.00139221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002548345,"about_ca_topic_score_gemma":0.004252719,"domain_scores_codex":[0.9931945,0.005078529,0.000498868,0.0005509288,0.0001818216,0.0004953869],"domain_scores_gemma":[0.9940216,0.002289225,0.001740302,0.0005886266,0.0003823618,0.0009777728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9614398,0.00155631,0.01621722,0.001024386,0.01416173,0.00009554499,0.0001030923,0.000404267,0.0005730814,0.00007679255,0.0002924485,0.004055223],"study_design_scores_gemma":[0.8513395,0.06142519,0.05884112,0.0003833784,0.02544471,0.0001259436,0.0002894188,0.0002809491,0.0006050211,0.0001847821,0.001007221,0.00007264827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913883,0.006549133,0.0001853781,0.0002409345,0.0001247852,0.0004070541,0.0006045733,0.000009660763,0.0004901887],"genre_scores_gemma":[0.9962037,0.001605255,0.0002437278,0.000269361,0.00009082464,0.0004079097,0.000844074,0.000005541691,0.0003296034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005992417,"threshold_uncertainty_score":0.03169131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04985732964424132,"score_gpt":0.3716480199964852,"score_spread":0.3217906903522438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}